SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiome -- CRME
CRME 2.330-2.1%May 16 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Ian@SI7/21/2006 2:33:36 PM
  Read Replies (3) of 285
 
Hope this was expected... I really hate unexpected conference calls...

Cardiome To Hold Conference Call

14:30 EDT Friday, July 21, 2006

<<
NASDAQ: CRME TSX: COM
>>

VANCOUVER, July 21 /CNW/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that a teleconference call and webcast will be held on Monday, July 24, 2006 at 9:00am EST (6:00am PST) to discuss interim results from the Phase 2a pilot study for RSD1235 (oral). A press release will be issued prior to the call.

The conference call will be hosted by Bob Rieder, Chief Executive Officer, Doug Janzen, President and Chief Business Officer and Dr. Charles Fisher, Executive Vice President and Chief Medical Officer.

To access the conference call, please dial 416-644-3432 or 800-814-4941. There will be a separate dial-in line for analysts on which we will respond to questions at the end of the call. The webcast can be accessed through Cardiome's website at cardiome.com.

Webcast and telephone replays of the conference call will be available approximately two hours after the completion of the call through August 24, 2006. Please dial 416-640-1917 or 877-289-8525 and enter code 21197657 followed by the number sign to access the replay.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext